Partner Content Partner Content The prevailing desire uniting patients, HCPs, and payers: a ... Milo Elmir on trends shaping stakeholder's behavior
Partner Content Partner Content Formedix launches Community Forum to support the clinical tr... Formedix launches the ryze Community Forum
Events Partner Content SMi’s 6th Annual Highly Potent Active Pharmaceutical Ingredi... SMi’s 6th Annual Highly Potent Active Pharmaceutical Ingredients 9th and 10th May 2022 London, UK www.highlypotentapi.com/pharmaphorum
Partner Content Partner Content 6 critical success factors of a successful rapid first comme... Annemarie Armstrong shares key factors for rapid launch
Partner Content Partner Content Formedix Partnered with CDISC to Give Free Access to CDASH-C... Free access to CDASH-Compliant eCRFs
Partner Content Partner Content How the Formedix ryze Visual Define-XML Editor Gives You Fas... Creating Define-XML files has never been easier!
News Genmab expands its pipeline with $630m Scancell deal Genmab has licensed another anti-glycan antibody for cancer from UK biotech Scancell as it continues to expand its in-house pipeline.
Digital Sponsored The AI effect in pharma commercial strategy: From data to re... Discover how AI is transforming the pharma commercial strategy. Unlock real-time insights & actions from data. Click here for more.
